Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Acadia Appoints Board Member

This article was originally published in Scrip

Executive Summary

Acadia Pharmaceuticals Inc. has appointed Edmund P. Harrigan to its board of directors. Currently Harrigan serves on the board of directors of Karuna Pharmaceuticals Inc. Previously he was senior vice president of worldwide safety and regulatory for Pfizer and also held various executive leadership roles at the company, including head of worldwide business development, head of worldwide regulatory affairs and quality assurance, and head of neuroscience and ophthalmology. Prior to entering the pharma industry Harrigan was a practicing neurologist.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC063844

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel